National Infection Service, Public Health England, London, United Kingdom.
South West Regional Public Health Laboratory, Public Health England, Bristol, United Kingdom.
Euro Surveill. 2019 Sep;24(38). doi: 10.2807/1560-7917.ES.2019.24.38.1900557.
We identified two new (CT) variants escaping Aptima Combo 2 (AC2) assay detection, in clinical specimens of two patients. One had a C1514T mutation the other a G1523A mutation, both within the AC2 23S rRNA target region. The prevalence of such variants among persons tested for CT in England was estimated to be fewer than 0.003%.
我们在两名患者的临床标本中发现了两种新的(CT)变体,能够逃避 Aptima Combo 2(AC2)检测。一种有 C1514T 突变,另一种有 G1523A 突变,均位于 AC2 23S rRNA 靶区域内。在英国接受 CT 检测的人群中,此类变体的流行率估计不到 0.003%。